Absci Corporation Stock (ABSI) Opinions on Investor Conference Participation

Conference participation announced: Social media chatter has centered on Absci's scheduled appearances at several investor events in the coming weeks. Observers note this as a platform for the company to outline its pipeline progress in AI-driven drug discovery. Market reactions emerge: Discussions highlight how these conferences could draw fresh attention to recent advancements shared by the firm. Some participants in the conversation point to ongoing interest in the biotech sector's integration of computational tools for antibody development. Broader context discussed: Analysts on social media have referenced the timing amid industry-wide focus on innovative therapies. The tone reflects measured curiosity about potential updates without widespread consensus on near-term outcomes. Note: This discussion summary was generated from an AI condensation of post data. Absci Corporation Insider Trading Activity Absci Corporation insiders have traded $ABSI stock on the open market 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales. Here's a breakdown of recent trading of $ABSI stock by insiders over the last 6 months: ANDREAS BUSCH (Chief Innovation Officer) purchased 100,000 shares for an estimated $229,000 MENELAS N PANGALOS purchased 37,453 shares for an estimated $200,748 MARY T SZELA purchased 12,900 shares for an estimated $148,866 To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint. Quiver Alerts Receive ABSI Data Alerts Get market-moving data, filings, and signals for ABSI in real time. Sign Up Absci Corporation Hedge Fund Activity We have seen 121 institutional investors add shares of Absci Corporation stock to their portfolio, and 77 decrease their positions in their most recent quarter. Here are some of the largest recent moves: ADAGE CAPITAL PARTNERS GP, L.L.C. added 5,704,820 shares (+inf%) to their portfolio in Q2 2026, for an estimated $66,118,863 D. E. SHAW & CO., INC. added 5,239,754 shares (+inf%) to their portfolio in Q2 2026, for an estimated $60,728,748 AMERIPRISE FINANCIAL INC added 3,811,622 shares (+119.9%) to their portfolio in Q2 2026, for an estimated $44,176,698 FMR LLC added 2,859,051 shares (+12.7%) to their portfolio in Q2 2026, for an estimated $33,136,401 TWO SIGMA INVESTMENTS, LP added 2,594,720 shares (+89.5%) to their portfolio in Q2 2026, for an estimated $30,072,804 BVF INC/IL added 2,361,674 shares (+inf%) to their portfolio in Q2 2026, for an estimated $27,371,801 MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 1,719,992 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $19,934,707 To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint. Absci Corporation Price Targets Multiple analysts have issued price targets for $ABSI recently. We have seen 6 analysts offer price targets for $ABSI in the last 6 months, with a median target of $14.0. Here are some recent targets: Srikripa Devarakonda from Truist Securities set a target price of $17.0 on 07/02/2026 on 07/02/2026 Swayampakula Ramakanth from HC Wainwright & Co. set a target price of $16.0 on 06/25/2026 on 06/25/2026 Kambiz Yazdi from BTIG set a target price of $13.0 on 06/24/2026 on 06/24/2026 Gil Blum from Needham set a target price of $11.0 on 06/24/2026 on 06/24/2026 Vamil Divan from Guggenheim set a target price of $15.0 on 06/15/2026 on 06/15/2026 Mani Foroohar from Leerink Partners set a target price of $12.0 on 06/04/2026 This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.